CONFIDENTIAL | BY INVITATION ONLY

BREAKING SCIENCE INTO SPORT

BY ATHLETES & SCIENTISTS | FOR GENERATIONS

lemon covered with water time-lapse photo
97% OF INVESTMENT IN SPORTS GOES TO ARENAS, MEDIA, BRANDS
BUT NOT THE BIOLOGY THAT FUELS HEALTH

BREAKING SCIENCE INTO SPORT

top three market point..

THE EDGE

The differentiation and why we win

THE ASK

The ask for the audience

man doing exercise position
man doing exercise position
Collisions of longevity biotechnology + sports, amplified by women

EXPLOSIVE DEMAND

Surging customer adoption rates with zero signs of slowing down.

HIGH THROUGH PUT AND SCALABLE

High-margin business model built for hyper-growth and rapid cash-flow generation.

ELITE EXECUTION

The co-founding of elite athelete with successful science

A woman jumping over a hurdle on a track
A woman jumping over a hurdle on a track
The elite athlete | SCIENTIST | INVESTOR
woman wearing sleeveless top
woman wearing sleeveless top
A sharp black and white studio portrait of a female venture partner in a dark structured blazer, looking forward, dramatic side lighting, dark background.
A sharp black and white studio portrait of a female venture partner in a dark structured blazer, looking forward, dramatic side lighting, dark background.
LEADERSHIP

The COfounders

CO-FOUNDER

CO-FOUNDER

ANGLEA

SANS

A former Olympic sports physiologist and biotech investor, Dr. Vance has spent two decades researching cellular longevity and athletic performance biology to redefine human health spans.

Elena brings fifteen years of venture capital leadership in deep tech and health systems, guiding TOWER’s global network of generational health assets and athlete partnerships.

POWERED WITH GENERATIONAL HEALTH SCIENCE & TECHNOLOGIES

$28B+ USD in networked Generational Health assets — by total invested capital

1,000+ generational health & science innovations vetted with TOWER R&D

5 continents of operating leadership and leading athlete partners

175+ years combined; 40+ medicines launched; multiple exit types

ATHLETES AS PARTNERS

VOTING INVESTMENT TEAM

ACTIVE ADVISORS

LEADING INVESTORS

BX

X

X

Engage directly with pioneering sports science. Athletes provide the elite human data that validates our biotechnology and longevity research.

Access exclusive, high-margin investment opportunities in sports biology and longevity portfolios alongside our core venture partners.

Drive the global narrative. Partners champion scientific breakthroughs, translating complex biotechnology into mainstream athletic authority.

• Clinical trial participation • Real-world data tracking • Performance optimization feedback

• Direct equity allocation • Portfolio co-investment • Generational wealth building

• Global brand ambassadorship • Media and advocacy leadership • Public category pioneering

VELOCITY & PROJECTIONS

THESIS

Surging customer adoption rates with zero signs of slowing down.

FUND STRUCUTRE

High-margin business model built for hyper-growth and rapid cash-flow generation.

PREMIUM OUTCOMES & PROJECTIONS

The co-founding of elite athelete with successful science

a close up of a blue and purple structure
a close up of a blue and purple structure
yellow ball on water during night time

Copyright 2026. Tower Capital Group. All Rights Reserved